Photos from Envato
The prevalence of the disease is expected to increase by 0.7% per year in seven major markets.
Despite significant advances in obesity treatment, challenges such as limited care opportunities remain, according to GlobalData.
Costanza Alciati, a pharmaceutical analyst at GlobalData, said there is an increasing importance of awareness of the needs of the disease and other diseases that may lead to it.
The prevalence of the disease is expected to increase by 0.7% per year in seven major markets by 2031.
“By 2031, GlobalData is expected to acquire 23 candidates in major markets. This will provide patients with a wider range of options and hope that treatment capacity will improve by then,” Alciati said.
Analysts add that access to experts and affordable treatments is also a barrier to the landscape.
7mm = United States, France, Germany, Italy, Spain, Britain and Japan.
Join the Healthcare Asia Magazine Community
Since you're here…
…You can promote your company with us and connect with your customers in a variety of ways. Our team can help you Dight and create advertising campaigns on print and digitally on this website and on print magazines.
We can also organize real-life or digital events for you and find thought leader speakers and industry leaders who can become your potential partners to attend. We also run a number of award programs that give you the opportunity to earn your achievements this year, and you can join as a participant or sponsor.
Let us help you move your business forward with a good partnership!
